BackBioNexus Gene Lab Overview

BioNexus Gene Lab Current Cash

Track BioNexus Gene Lab's current cash ($1.3M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$1.34M
↑ 22.58% YoYΔ $246353.00 vs prior year quarter

Peer average

Loading

BioNexus Gene Lab Current Cash History

Loading

BioNexus Gene Lab vs. peers: Current Cash Comparison

Loading

BioNexus Gene Lab Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

BioNexus Gene Lab (BGLC) FAQ

As of the most recent data (March 2026), BGLC shows a current cash of $1.3M. That compares with $1.1M in the prior-year period — up 22.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BGLC's current cash is now $1.3M (was $1.1M) — a 22.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether BioNexus Gene Lab is outperforming or lagging.

Tracking BGLC's current cash over time shows whether BioNexus Gene Lab is scaling, shrinking, or reshaping that part of the business. The current reading is $1.3M That compares with $1.1M in the prior-year period — up 22.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has BioNexus Gene Lab's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $1.3M) with ownership activity and broader fundamentals.